Treatment Duration for HSV Pneumonia
For proven HSV pneumonia, treat with intravenous acyclovir 5-10 mg/kg every 8 hours for 14-21 days, continuing until clinical resolution is achieved. 1, 2
Treatment Approach
The treatment duration for HSV pneumonia should follow the same principles established for HSV encephalitis, as both represent severe, life-threatening HSV infections requiring prolonged therapy:
Standard Duration: 14-21 Days
- Intravenous acyclovir is the treatment of choice at 5-10 mg/kg every 8 hours 3, 4
- The original trials used 10 days, but clinical relapses led to extending treatment to 14-21 days 1, 2
- Continue therapy until complete clinical resolution is achieved 3, 4
Key Clinical Considerations
For immunocompromised patients:
- May require longer treatment courses beyond 21 days 1
- Continue therapy until clinical resolution, which may take longer than in immunocompetent hosts 3
- Consider repeat diagnostic testing if clinical improvement is inadequate
Monitoring during treatment:
- Maintain adequate hydration to prevent acyclovir-induced nephropathy (occurs in up to 20% of patients after 4 days of IV therapy) 1, 2
- Monitor renal function at initiation and once or twice weekly during treatment 5
- Adjust dosing in patients with pre-existing renal impairment 2
Important Caveats
Distinguishing True Infection from Colonization
This is a critical challenge in HSV pneumonia. HSV detection in respiratory specimens does not automatically indicate true infection 6, 7:
- True HSV pneumonia requires: clinical symptoms + HSV in lower respiratory tract + either cytopathic effects on bronchoalveolar lavage cells OR HSV load >10^5 copies/million cells 8
- Consider treatment when viral load is high (>10^5 copies/million cells) even without definitive cytopathology 8
- Clinical deterioration despite appropriate antibacterial therapy should raise suspicion 6
Treatment Resistance
If lesions or clinical symptoms persist after 7-10 days of appropriate therapy:
- Suspect acyclovir resistance 5, 9
- Switch to foscarnet 40 mg/kg IV every 8 hours until clinical resolution 3, 5
- All acyclovir-resistant strains are also resistant to valacyclovir, and most to famciclovir 3
Special Populations
Critically ill/mechanically ventilated patients:
- HSV reactivation occurs in 20-50% of ICU patients 8
- Progression from throat to lung typically takes 7-10 days 8
- Longer mechanical ventilation is associated with HSV bronchopneumonitis 10
- Treatment should be based on clinical presentation plus corroborative findings 7
Patients on corticosteroids:
- Steroids can precipitate HSV reactivation and worsen disease 11
- Consider discontinuing steroids when HSV pneumonia is diagnosed 11
Algorithm for Treatment Decisions
Confirm diagnosis: Clinical pneumonia + HSV in lower respiratory tract + cytopathic effects or high viral load (>10^5 copies/million cells)
Initiate IV acyclovir: 5-10 mg/kg every 8 hours
Ensure adequate hydration and monitor renal function
Assess response at 7-10 days:
- If improving: Continue to complete 14-21 days total
- If not improving: Consider resistance, switch to foscarnet
Continue until complete clinical resolution, which may extend beyond 21 days in immunocompromised patients
The evidence strongly supports prolonged treatment (14-21 days minimum) rather than shorter courses, as relapse rates are significantly higher with treatment durations <14 days, particularly in vulnerable populations 2.